WESTLAKE VILLAGE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter ...
Second, not all the cancer cells necessarily have the structure the T-cells can recognize and attack. And third, solid tumors in human tissue have a microenvironment that fends off immune system ...